Willow Biosciences
C$0.09
14
+C$0+0% Tuesday 18:20
统计数据
当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
13.7M
市盈率
-
股息收益率
-
股息
-
即将到来
收益
13Nov预期
预期每股收益
N/A
实际每股收益
N/A
人们还关注
此列表基于关注WLLW.TO的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
CRISPR Therapeutics
CRSP
市值4.06B
Editas Medicine
EDIT
市值308.46M
Intellia Therapeutics
NTLA
市值2.28B
Evogene
EVGN
市值18.45M
Synlogic
SYBX
市值17.31M
Adaptive Biotechnologies
ADPT
市值693.12M
Twist Bioscience
TWST
市值2.53B
Co-Diagnostics
CODX
市值44.36M
Pacific Biosciences of California
PACB
市值373.36M
关于
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Show more...
首席执行官
Mr. Travis Doupe
员工
19
国家
CA
ISIN
CA97111B4047